Bank A
Schweiz Med Wochenschr. 1983 Oct 8;113(40):1415-9.
Two newly developed techniques have greatly enlarged our knowledge of the basic genetic defects of the beta-thalassemias: 1) Restriction enzyme digestion of cellular DNA followed by analysis of the cleaved fragments. 2) Cloning of beta-globin genes from patients with beta-thalassemia and subsequent determination of the nucleotide sequence of these genes. Some of the results are presented. Only rarely a deletion of the beta-globin gene was found. In most cases, a mutation within the beta-globin gene was discovered as basis for the beta-thalassemia syndrome. These and other findings are a starting point for planning a therapy of beta-thalassemia by means of gene technology: correction of the defect within the abnormal beta-globin gene, replacement of the beta-globin gene, stimulation of gamma-globin synthesis.
两项新开发的技术极大地扩展了我们对β地中海贫血基本基因缺陷的认识:1)对细胞DNA进行限制性酶切,然后分析切割后的片段。2)从β地中海贫血患者中克隆β珠蛋白基因,并随后测定这些基因的核苷酸序列。现将部分结果呈现如下。仅偶尔发现β珠蛋白基因缺失。在大多数情况下,发现β珠蛋白基因内的突变是β地中海贫血综合征的基础。这些以及其他发现是通过基因技术规划β地中海贫血治疗方案的起点:纠正异常β珠蛋白基因内的缺陷、替换β珠蛋白基因、刺激γ珠蛋白合成。